Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stinchcombe

Showing results (441-450 of 575) with videos related to

Pageof 58
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 28, 2006
Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapyThomas E Stinchcombe, David E Morris, Dominic T Moore, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2015
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groupsXiaofei Wang, Lin Gu, Ying Zhang, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|May 31, 2013
Effects of estrogen coadministration on epoxiconazole toxicity in ratsStefan Stinchcombe, Steffen Schneider, Ivana Fegert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2020
Novel Variants of <i>ELP2</i> and <i>PIAS1</i> in the Interferon Gamma Signaling Pathway Are Associated with Non-Small Cell Lung Cancer SurvivalYu Chen Zhao, Dongfang Tang, Sen Yang, et al.
Current Medical Research and Opinion|March 10, 2017
Meta-analysis of pemetrexed plus carboplatin doublet safety profile in first-line non-squamous non-small cell lung cancer studiesIsamu Okamoto, Wolfgang H W Schuette, Thomas E Stinchcombe, et al.
Science (New York, N.Y.)|February 18, 2003
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeletonTadahiko Igakura, Jane C Stinchcombe, Peter K C Goon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancerCarrie B Lee, Thomas E Stinchcombe, Dominic T Moore, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|November 7, 2023
Older Drivers Reduced Engagement in Distracting Behaviors Over a Six-Year Period: Findings From the Candrive Longitudinal StudyMichel Bédard, Hillary Maxwell, Bruce Weaver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2012
Phase I study of aurora A kinase inhibitor MLN8237 in advanced solid tumors: safety, pharmacokinetics, pharmacodynamics, and bioavailability of two oral formulationsE Claire Dees, Roger B Cohen, Margaret von Mehren, et al.
Plos Computational Biology|May 28, 2021
Targeted modification of the Per2 clock gene alters circadian function in mPer2luciferase (mPer2Luc) miceMartin R Ralph, Shu-Qun Shi, Carl H Johnson, et al.
Pageof 58

Showing results (441-450 of 575) with videos related to

Sort By:
Pageof 58
Lung Cancer (Amsterdam, Netherlands)|February 28, 2006
Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapyThomas E Stinchcombe, David E Morris, Dominic T Moore, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2015
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groupsXiaofei Wang, Lin Gu, Ying Zhang, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|May 31, 2013
Effects of estrogen coadministration on epoxiconazole toxicity in ratsStefan Stinchcombe, Steffen Schneider, Ivana Fegert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2020
Novel Variants of <i>ELP2</i> and <i>PIAS1</i> in the Interferon Gamma Signaling Pathway Are Associated with Non-Small Cell Lung Cancer SurvivalYu Chen Zhao, Dongfang Tang, Sen Yang, et al.
Current Medical Research and Opinion|March 10, 2017
Meta-analysis of pemetrexed plus carboplatin doublet safety profile in first-line non-squamous non-small cell lung cancer studiesIsamu Okamoto, Wolfgang H W Schuette, Thomas E Stinchcombe, et al.
Science (New York, N.Y.)|February 18, 2003
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeletonTadahiko Igakura, Jane C Stinchcombe, Peter K C Goon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancerCarrie B Lee, Thomas E Stinchcombe, Dominic T Moore, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|November 7, 2023
Older Drivers Reduced Engagement in Distracting Behaviors Over a Six-Year Period: Findings From the Candrive Longitudinal StudyMichel Bédard, Hillary Maxwell, Bruce Weaver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2012
Phase I study of aurora A kinase inhibitor MLN8237 in advanced solid tumors: safety, pharmacokinetics, pharmacodynamics, and bioavailability of two oral formulationsE Claire Dees, Roger B Cohen, Margaret von Mehren, et al.
Plos Computational Biology|May 28, 2021
Targeted modification of the Per2 clock gene alters circadian function in mPer2luciferase (mPer2Luc) miceMartin R Ralph, Shu-Qun Shi, Carl H Johnson, et al.
Pageof 58